Potent antibacterial antisense peptide-peptide nucleic acid conjugates against pseudomonas aeruginosa

Nucleic Acid Therapeutics

Volumn 22, Issue 5, 2012, Pages 323-334

  Ghosal, Anubrata ^a   Nielsen, Peter E ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; OFLOXACIN; PEPTIDE NUCLEIC ACID;

ACPP GENE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG POTENCY; FATTY ACID SYNTHESIS; FTSZ GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PSEUDOMONAS AERUGINOSA;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; CELL SURVIVAL; CELL-PENETRATING PEPTIDES; DRUG CARRIERS; HELA CELLS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDE NUCLEIC ACIDS; PSEUDOMONAS AERUGINOSA;

BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 84870376877     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2012.0370     Document Type: Article

References (31)

1. ABES, S., MOULTON, H., TURNER, J., CLAIR, P., RICHARD, J. P., IVERSEN, P., GAIT, M. J., and LEBLEU, B. (2007). Peptidebased delivery of nucleic acids: design, mechanism of uptake and applications to splice-correcting oligonucleotides. Biochem. Soc. Trans. 35, 53-55.
2. ABES, S., MOULTON, H. M., CLAIR, P., PREVOT, P., YOUNGBLOOD, D. S., WU, R. P., IVERSEN, P. L., and LEBLEU B. (2006). Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents. J. Control. Release. 116, 304-313. (Pubitemid 44827406)
3. AMANTANA, A., MOULTON, H. M., CATE, M. L., REDDY, M. T., WHITEHEAD, T., HASSINGER, J. N., YOUNGBLOOD, D. S., and IVERSEN, P. L. (2007). Pharmacokinetics, biodistribution, stability, and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate. Bioconjug. Chem. 18, 1325-1331. (Pubitemid 47122656)
4. BAI, H., YOU, Y., YAN, H., MENG, J., XUE, X., HOU, Z., ZHOU, Y., MA, X., SANG, G., ad LUO, X. (2012). Antisense inhibition of gene expression and growth in gram-negative bacteria by cell-penetrating peptide conjugates of peptide nucleic acids targeted to rpoD gene. Biomaterials. 33, 659-667.
5. BOTZENHART, K., and DÖ RING, G. (1993). Epidemiology and ecology of Pseudomonas aeruginosa. In: Pseudomonas aeruginosa as an opportunistic pathogen. Campa, M., et al., eds. Plenum Publishing Cooperation, New York pp. 1-18.
6. CHRISTENSEN, L., FITZPATRICK, R., GILDEA, B., PETERSEN, K. H., HANSEN, H. F., KOCH, T., EGHOLM, M., BUCHARDT, O., NIELSEN, P. E., COULL, J., and BERG, R. H. (1995). Solid-phase synthesis of peptide nucleic acids. Peptide Sci. 1,175-183
7. DÖ RING, G., CONWAY, S. P., HEIJERMAN, H. G., HODSON, M. E., HOIBY, N., SMYTH, A., and TOUW, D. J. (2000). Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur. Respir. J. 16, 749-767.
8. DÖ RING, G., and HØIBY, N. (2004). Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J. Cyst. Fibros. 3, 65-91.
9. DRYSELIUS, R., NEKHOTIAEVA, N., NIELSEN, P. E., and GOOD, L. (2003b). Antibiotic-free bacterial strain selection using antisense peptide nucleic acid. Bio. Techniques. 35, 1060-1064. (Pubitemid 37413429)
10. DRYSELIUS, R., ASWASTI, S. K., RAJARAO, G. K., NIELSEN, P. E., and GOOD, L. (2003a). The translation start codon region is sensitive to antisense PNA inhibition in Escherichia coli. Oligonucleotides 13, 427-433 (Pubitemid 38296142)
11. ECKERT, R., FENGXIA, Q. I., YARBROUGH, D. K., JIAN, H. E., ANDERSON, M. H., and WENYUAN, S.H.I. (2006). Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp. Antimicrob. Agents Chemother. 50, 1480-1488
12. GELLER, B. L. (2005). Antibacterial antisense. Curr. Opin Mol. Ther. 7, 109-113 (Pubitemid 40514679)
13. GOH, S., BOBEREK, J. M., NAKASHIMA, N., STACH, J., and GOOD, L. (2009). Concurrent growth rate and transcript analyses reveal essential gene stringency in Escherichia coli. PLoS One 4, e6061.
14. GOOD, L., AWASTHI, S. K., DRYSELIUS, R., LARSSON, O., and NIELSEN, P. E. (2001). Bactericidal antisense effects of peptide-PNA conjugates. Nat. Biotechnol. 19, 360-364. (Pubitemid 32275346)
15. GOOD, L., and NIELSEN, P. E. (1998). Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA. Nat. Biotechnol. 16, 355-358. (Pubitemid 28164655)
16. GREENBERG, D. E., MARSHALL-BATTY, K. R., BRINSTER, L. R., ZAREMBER, KA., SHAW, PA., MELLBYE, BL., IVERSEN, PL., HOLLAND, SM., GELLER, BL. (2010). Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex. J. Infect. Dis. 12, 1822-1830.
17. GRUEGELSIEPE, H., BRANDT, O., and HARTMANN, RK. (2006). Antisense Inhibition of RNase P. J. Biol. Chem. 281, 30613-30620.
18. HU, J., XIA. Y., XIONG, Y., L. I, X., and SU, X. (2011). Inhibition of biofilm formation by the antisense peptide nucleic acids targeted at the motA gene in Pseudomonas aeruginosa PAO1strain. World J. Microbiol. Biotechnol. 27, 1981-1987.
19. IBRULJ, I. K., BRAGONZI, A., PARONI, M., WINSTANLEY, C., SANSCHAGRIN, F., O'TOOLE, G. A. and LEVESQUE, RC. (2008). In vivo growth of Pseudomonas aeruginosa strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model of chronic lung infection. J. Bacteriol. 190, 2804-2281.
20. KURUPATI, P., TAN, K. S., KUMARASINGHE, G., and POH, C. L. (2007). Inhibition of gene expression and growth by antisense peptide nucleic acids in a multiresistant beta-lactamaseproducing Klebsiella pneumoniae strain. Antimicrob. Agents Chemother. 51, 805-811. (Pubitemid 46355259)
21. MELLBYE, B. L., PUCKETT, S. E., TILLEY, L. D., IVERSEN, P. L. and GELLER, B. L. (2009). Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo. Antimicrob Agents Chemother. 55, 525-530.
22. MELLBYE, B. L., WELLER, D. D., HASSINGER, J. N., REEVES, M. D., LOVEJOY, C. E., IVERSEN, P. L., and GELLER, B. L. (2010). Cationic phosphorodiamidate morpholino oligomers efficiently prevent growth of Escherichia coli in vitro and in vivo. J. Antimicrob. Chemother. 65, 98-106.
23. NEKHOTIAEVA, N., AWASTHI, S. K., NIELSEN, P. E., and GOOD, L. (2004). Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids. Mol. Ther. 10, 652-659. (Pubitemid 39272854)
24. NIKRAVESH, A., DRYSELIUS, R., FARIDANI, O. R., GOH, S., SADEGHIZADEH, M., BEHMANESH, M., GANYU, A., KLOK, E. J., ZAIN, R., and GOOD, L. (2007). Antisense PNA accumulates in Escherichia coli and mediates a long post-antibiotic effect. Mol. Ther. 15, 1537-1542. (Pubitemid 47099311)
25. ROTH, B. L., POOT, M., YUE, S. T., and MILLARD, P. J. (1997). Bacterial viability and antibiotic susceptibility testing with sytox green nucleic acid stain. Appl. Environ. Microbiol. 63, 2421-2431. (Pubitemid 27232947)
26. SABBATH, L. D. (1980). Pseudomonas aeruginosa, the organism, diseases it causes, and their treatment. (Hans Huber Publishers. Bern), pp. 31-51.
27. SADIKOT, R. T., BLACKWELL, T. S., CHRISTMAN, J. W., and PRINCE, A. S. (2005). Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 171, 1209-1223. (Pubitemid 40740727)
28. SALEH, A. F., ARZUMANOV, A., ABES, R., OWEN, D., LEBLEU, B., an GAIT, M. J. (2010). Synthesis and spliceredirecting activity of branched, arginine-rich peptide dendrimer conjugates of peptide nucleic acid oligonucleotides. Bioconjug. Chem. 21, 1902-1911.
29. SÁ NCHEZ, G. S., JAPELJ, B., JERALA, R., MORIYÓ N, I., FERNA ́ NDEZ, A. M., LEIVA, J., BLONDELLE, S. E., ANDRÄ, J., BRANDENBURG, K., LOHNER, K., and MARTÍNEZ, T. G. (2010). Structural features governing the activity of lactoferricin-derived peptides that act in synergy with antibiotics against Pseudomonas aeruginosa in vitro and in vivo. Antimicrob. Agents Chemother. 55, 218-228.
30. SRINIVAS, N., JETTER, P., UEBERBACHER, B. J., WERNEBURG, M., ZERBE, K., STEINMANN, J., VANDER, M. B., BERNARDINI, F., LEDERER, A., DIAS, R, L., et al. (2010). Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science 327, 1010-1013.
31. TAN, X. X., ACTOR, J. K., and CHEN, Y. (2005). Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection. Antimicrob. Agents Chemother. 49, 3203-3207. (Pubitemid 41060562)